BCBS says second complaint in specialty testing antitrust case still fails to allege a conspiracy
MLex Summary: Blue Cross Blue Shield has filed a motion to dismiss the second amended complaint alleging that it conspired to restrain competition in the sale of routine, molecular, and specialty testing...To view the full article, register now.
Already a subscriber? Click here to view full article